Model 1 | Model 2 | |||
---|---|---|---|---|
Characteristic | ß (95% CI) | p | ß (95% CI) | p |
RA duration, per year | 0.001 (−0.004, 0.006) | 0.65 | −0.003 (−0.008, 0.003) | 0.33 |
Age at RA diagnosis, per year | 0.006 (0.002, 0.010) | 0.007 | 0.002 (−0.003, 0.008) | 0.33 |
DAS28-CRP | −0.022 (−0.073, 0.029) | 0.39 | 0.005 (−0.044, 0.054) | 0.84 |
Any SE alleles | 0.026 (−0.092, 0.144) | 0.66 | 0.020 (−0.088, 0.127) | 0.72 |
Total Sharp score, per 10 units | 0.003 (−0.003, 0.010) | 0.35 | 0.002 (−0.004, 0.008) | 0.54 |
HAQ, per unit | 0.039 (−0.035, 0.113) | 0.30 | 0.044 (−0.028, 0.116) | 0.23 |
Log CRP | 0.002 (−0.039, 0.043) | 0.91 | −0.026 (−0.065, 0.012) | 0.18 |
Log IL-6 | −0.010 (−0.067, 0.047) | 0.72 | −0.039 (−0.091, 0.014) | 0.15 |
Current prednisone use | −0.100 (−0.211, 0.012) | 0.079 | −0.056 (−0.161, 0.050) | 0.30 |
Cumulative prednisone | −0.001 (−0.007, 0.004) | 0.65 | −0.001 (−0.006, 0.004) | 0.63 |
Current nonbiologic DMARD | −0.022 (−0.017, 0.129) | 0.78 | 0.011 (−0.127, 0.150) | 0.87 |
Current biologic DMARD | −0.017 (−0.126, 0.093) | 0.76 | 0.045 (−0.053, 0.145) | 0.36 |
Model 1: crude model, no adjustment. Model 2: adjusted for systolic and diastolic blood pressure, antihypertensive use, HDL-C, LDL-C, use of lipid lowering medications, diabetes, and ever smoking. Definitions: See legend to Table 3.